Sandip Kapadia — CFO & Treasurer at Intercept Pharmaceuticals

Mr. Sandip S. Kapadia has been the Chief Financial Officer and Treasurer of Intercept Pharmaceuticals, Inc. since July 1, 2016. Mr. Kapadia served as the Chief Financial Officer, Head of Finance for North America and Vice President at Sandoz Inc. He has over 19 years of experience in building and leading finance and administration teams at life sciences companies both in the United States and abroad. Mr. Kapadia joins Intercept from Sandoz, Inc., a division of Novartis AG, where he served as vice president and chief financial officer ??? North America from 2014 to 2016. From 2012 to 2014, Mr. Kapadia served as vice president and chief financial officer of Novartis Pharmaceuticals UK Limited. Mr. Kapadia also served as vice president and chief financial officer of Novartis Pharmaceuticals B.V. located in the Netherlands from 2009 through 2012. Prior to that, he served as head of finance ??? oncology business unit for both Novartis Pharmaceuticals A.G. and Novartis Pharmaceuticals Corporation. Mr. Kapadia earned his bachelor degree in business administration and accounting from Montclair State University, an M.B.A from Rutgers Graduate School of Management and is a certified public accountant.